Neridronate preferentially suppresses the urinary excretion of peptide- bound deoxypyridinoline in postmenopausal women

Calcified Tissue International

Volumn 59, Issue 5, 1996, Pages 407-409

  Tobias, J H ^a   Laversuch, C V ^b   Wilson, N ^c   Robins, S P ^c  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Bisphosphonate; Collagen Crosslink; Deoxypyridinoline; Neridronate

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; NERIDRONIC ACID; PYRIDONE DERIVATIVE;

ADULT; ARTICLE; BONE METABOLISM; BONE MINERALIZATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COLLAGEN SYNTHESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; URINARY EXCRETION;

ADMINISTRATION, ORAL; AMINO ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIPHOSPHONATES; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE;

EID: 0029956728     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900148     Document Type: Article

References (20)

1. Robins SP, Duncan A (1987) Pyridinium crosslinks of bone collagen and their location in peptides isolated from rat femur. Biochim Biophys Acta 914:233-239
2. Eyre DR, Koob TJ, Van Ness KP (1984) Quantitation of hydroxypyridinium cross-links incollagen by high-performance liquid chromatography. Anal Biochem 137:380-388
3. Seibel MJ, Robins SP, Bilezikian JP (1992) Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 4:204-270
4. Black D, Duncan A, Robins SP (1988) Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 137:480-488
5. Seyedin SM, Kung VT, Daniloff YN, Hesley RP, Gomez B, Nielsen LA, Rosen HN, Zuk RF (1993) Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone and Min Res 8:635-641
6. Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ (1994) Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a marker for measuring bone resorption. J Bone and Min Res 9:1643-1649
7. Hanson DA, Weiss MAE, Bollen AM, Maslan SH, Singer ER, Eyre DR (1992) A specific immunoassay for monitoring human bone resorption by quantitation of type 1 collagen cross-linked N-telopeptides in urine. J Bone and Min Res 7:1251-1258
8. Bonde M, Qvist P, Fidelius C, Riis BJ, Christiansen C (1994) Immunoassay for quantifying type 1 collagen degradation products in urine evaluated. Clin Chem 40:2022-2025
9. Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD (1995) Different effects of bisphosphonate and estrogen therapy on free and peptide-bound cross-links excretion. J Bone and Min Res 10:641-649
10. Blumsohn A, Naylor KE, Assiri AMA, Eastell R (1995) Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget Disease. Clin Chem 41:1592-1598
11. Pratt DA, Daniloff Y, Duncan A, Robins SP (1992) Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase extraction and reversed-phase high-performance liquid chromatography. Anal Biochem 207:168-175
12. Schenk R, Eggli P, Felix R, Fleisch H, Rosini S (1986) Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat. Calcif Tiss Int 38:342-349
13. Atkins RM, Yates AJP, Gray RES, Urwin GH, Hamdy NAT, Beneton MNC, Rosini S, Kanis JA (1987) Aminohexane Diphosphonate in the treatment of Paget's disease of bone. J Bone and Min Res 2:273-270
14. Coulton LA, Preston CJ, Couch M, Kanis JA (1988) An evaluation of serum osteocalcin in Paget's disease of bone and its response to diphosphonate treatment. Arthritis and Rheum 31:1142-1147
15. Delmas PD, Chapuy M-C, Edouard C, Meunier PJ (1987) Beneficial effects of Aminohexane Diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate. Am J Med 83:276-282
16. Garnero P, Shih WJ, Ginetys E, Karpf DB, Delmas PD (1994) Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate therapy. J Clin Endocrinol Metab 79:1693-1700
17. Eyre DR, Dickson IR, Van Ness KP (1988) Collagen crosslinking of human bone and cartilage: age-related changes in the content of mature hydroxypyridinium residues. Biochem J 252:495-500
18. Seibel MJ, Duncan A, Robins SP (1989) Urinary hydroxypyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 16:964-970
19. Scott D, Abu Damir H, Buchan W, Duncan A, Robins SP (1993) Factors affecting urinary pydridinoline and deoxypyridinoline excretion in the growing lamb. Bone 14:807-811
20. Robins SP (1995) Collagen crosslinks in metabolic bone diseases. Acta Orthop Scand 66(Supplement 266): 176-182